EUDAMED Registration: Where Most Teams Lose Clinical Data

Written by HATEM RABEH, MD, MSc Ing

Your Clinical Evaluation Expert And Partner

in
S

This happens more often than it should. EUDAMED clinical investigation registration is not intuitive. The system enforces a strict logic that does not match how most teams plan their studies. If you register modules in the wrong order, you create gaps that are difficult to fix without starting over.

The problem is not just technical. It reflects a deeper misunderstanding of how the MDR structures clinical investigation data and how that data flows between sponsors, ethics committees, Notified Bodies, and competent authorities.

Let me walk you through the actual registration process, step by step, with the context you need to avoid the common traps.

Why EUDAMED Registration Is Not Optional

Under MDR Article 62, sponsors must register clinical investigations in EUDAMED before the investigation begins. This is not a courtesy notification. It is a legal requirement.

The registration serves multiple functions. It creates a public record of the investigation. It allows competent authorities to track what is happening in their territories. It enables coordination when a single investigation spans multiple Member States.

But the real impact is operational. Without a valid EUDAMED registration, you cannot legally initiate subject enrollment in the EU. If you start enrollment before registration, you are conducting an unauthorized clinical investigation. That triggers enforcement action, not just a warning letter.

The Registration Sequence: What Most Teams Get Wrong

EUDAMED clinical investigation registration is modular. You do not fill out one form. You complete multiple interconnected modules in a specific sequence. If you break that sequence, you create data inconsistencies the system cannot resolve.

Here is the correct order:

Step 1: Register the Device in the UDI-DI Module

Before you can register a clinical investigation, the device itself must exist in EUDAMED as a UDI-DI record. This is the device identifier that links everything together.

If your device is already on the market with a UDI-DI, you reference that existing record. If the device is investigational and not yet marketed, you must create a temporary UDI-DI record specifically for the clinical investigation.

Most teams skip this step or assume someone else has handled it. That assumption breaks the entire registration process.

Step 2: Register the Sponsor Actor

The sponsor must be registered as an economic operator in EUDAMED. This is the legal entity responsible for the investigation.

If your organization is already registered as a manufacturer or authorized representative, that actor profile should already exist. But if you are a clinical research organization or academic institution sponsoring a study, you need to create a new actor profile specifically for this role.

The actor registration requires a Single Registration Number (SRN). You cannot proceed with clinical investigation registration until the SRN is active.

This step often takes longer than expected because teams underestimate the validation process. The SRN is not issued instantly. It requires verification, and that verification can take days or weeks depending on the competent authority workload.

Step 3: Complete the Clinical Investigation Module

Now you register the actual clinical investigation. This module contains the core information about the study: objectives, design, population, endpoints, risk assessment.

Here is where the logic becomes strict. You must declare whether the investigation is a single-center or multi-center study. You must specify which Member States are involved. You must link the investigation to the device UDI-DI you registered in Step 1.

If any of that foundational data is missing or inconsistent, the system blocks you from completing the registration.

One critical field that causes repeated problems: the investigation type. You must classify the study according to MDR Article 62(4). Is this a standard clinical investigation? A performance study? An investigation involving vulnerable populations?

The classification determines what additional documentation you must upload and what review pathways the competent authorities will follow. If you classify incorrectly, you trigger the wrong review process, and that creates delays that are difficult to reverse.

Step 4: Register Ethics Committee Approval

After you register the investigation, you must link the ethics committee approval. This is not optional. MDR Article 62(4) requires that the registration include evidence of favorable ethics opinion before the investigation can start.

You upload the ethics approval documents directly into EUDAMED. The system timestamps the upload. That timestamp becomes part of the official record.

The common mistake here is uploading a conditional ethics approval. If the ethics committee has requested changes or clarifications, and you have not yet addressed them, the approval is not final. Uploading a conditional approval and proceeding with enrollment creates a compliance gap.

Competent authorities notice this during inspections. They compare the EUDAMED record with the actual ethics committee correspondence. If there is a mismatch, it signals poor oversight.

Step 5: Link Competent Authority Notification

In parallel with ethics approval, you must notify the competent authority in each Member State where the investigation will be conducted. Under MDR Article 70, the competent authority has the right to review and object to the investigation.

EUDAMED tracks this notification. You register the notification in the system, and the competent authority uses EUDAMED to access your submission documents.

If the competent authority does not object within the defined timeframe, you can proceed. But you cannot proceed before that timeframe expires, even if the authority has informally indicated no objection.

Teams often confuse silence with approval. Silence is not approval. It is the absence of objection, which is different. EUDAMED enforces this distinction by locking enrollment activation until the review period has passed.

What Happens When You Get the Sequence Wrong

If you attempt to register modules out of order, EUDAMED will block you at various points. The system is designed to enforce dependencies.

But the real problem is not the immediate block. The real problem is what happens when you try to fix it later.

Let me give you an example from a project I reviewed last year. The team registered the clinical investigation before finalizing the UDI-DI. They used a placeholder identifier, assuming they could update it later. EUDAMED accepted the registration because the placeholder format was technically valid.

Three months into the study, the actual UDI-DI was finalized. The team tried to update the registration to link the correct identifier. EUDAMED flagged this as a major protocol amendment because it changed the device definition.

That triggered a new ethics review and a new competent authority notification period. The study was paused for six weeks while the amendment was processed. Enrollment timelines collapsed. Budget overruns cascaded.

All of this could have been avoided by completing the UDI-DI registration before starting the clinical investigation registration.

The Role of EUDAMED in Multi-State Investigations

When your investigation spans multiple Member States, EUDAMED becomes the coordination hub. You register the investigation once, but you link it to multiple competent authorities.

Each competent authority reviews the investigation independently. They use EUDAMED to access your documents. They upload their decisions into the system. You track all of this through a single interface.

This sounds efficient, but it creates timing complexity. Different Member States have different review timelines. Some respond quickly. Others take the full statutory period.

You cannot start enrollment in any Member State until both the ethics approval and the competent authority review are complete for that specific Member State. Even if three Member States have cleared the study, you must wait for the fourth before you can activate that site.

EUDAMED tracks this at the site level. If you attempt to enroll a subject at a site before both approvals are recorded in the system, you are operating outside the legal framework.

I have seen teams assume that a single EU-wide ethics approval covers all sites. That is not how the MDR works. Ethics approval is national or local, depending on the Member State structure. You must register each ethics approval separately in EUDAMED.

Amendments and Updates: How the System Tracks Changes

Once the investigation is registered and active, any material change to the protocol, device, or sponsor requires an amendment in EUDAMED.

The system distinguishes between substantial and non-substantial amendments. Substantial amendments require new ethics and competent authority reviews. Non-substantial amendments are recorded but do not trigger new review cycles.

The classification of substantial versus non-substantial is not always obvious. MDCG guidance provides general principles, but the final determination often depends on how the ethics committee and competent authority interpret the change.

What EUDAMED does is create an audit trail. Every amendment is timestamped and version-controlled. Reviewers can see the entire history of the investigation, including what was changed, when, and why.

This transparency is valuable for oversight, but it also means that mistakes are visible and permanent. If you submit an amendment with incorrect data, that error becomes part of the official record. You can correct it with a subsequent amendment, but you cannot erase the original entry.

Common Questions I Get About EUDAMED Registration

Can you register a clinical investigation before you have ethics approval?

Yes. You can initiate the registration and complete most fields before ethics approval is finalized. But you cannot activate the investigation or begin enrollment until the ethics approval is uploaded and linked in EUDAMED.

What happens if the competent authority objects after you have registered?

The investigation is placed on hold. You must address the competent authority concerns, submit revised documents, and wait for a new review period. EUDAMED tracks the hold status and prevents enrollment activation until the hold is lifted.

Do you need to register feasibility studies?

It depends. If the feasibility study involves intervention on human subjects and meets the definition of a clinical investigation under MDR Article 2(45), then yes. If it is purely observational or retrospective, it may not require registration. This is a case-by-case determination.

Can you transfer a clinical investigation registration from one sponsor to another?

Yes, but it requires a formal amendment. The new sponsor must be registered as an actor in EUDAMED. The transfer must be approved by ethics committees and competent authorities in all involved Member States. This is not a simple administrative update.

What This Means for Your Planning

EUDAMED registration is not something you handle in the final weeks before study start. It is a structured process that requires advance planning and cross-functional coordination.

You need your regulatory team, your quality team, and your clinical operations team working together. Each group owns different pieces of the registration, and those pieces must align.

If your device does not have a UDI-DI yet, that becomes the critical path. If your sponsor entity has never registered in EUDAMED, that becomes the critical path. If your protocol is still evolving, you cannot finalize the registration.

Build these dependencies into your project timeline. Do not assume EUDAMED registration is a one-day task. It is a multi-week process with external dependencies you do not fully control.

The system is live. The data is public. The competent authorities are watching. This is not rehearsal.

Peace,
Hatem
Clinical Evaluation Expert for Medical Devices
Follow me for more insights and practical advice.